Search Results - "Sabater, F.J"

  • Showing 1 - 17 results of 17
Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

    Methods applied in cost-effectiveness models for treatment strategies in type 2 diabetes mellitus and their use in Health Technology Assessments: a systematic review of the literature from 2008 to 2013 by Charokopou, M., Sabater, F.J., Townsend, R., Roudaut, M., McEwan, P., Verheggen, B.G.

    Published in Current medical research and opinion (01-02-2016)
    “…Objective: To identify and compare health-economic models that were developed to evaluate the cost-effectiveness of treatments for type 2 diabetes mellitus…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8
  9. 9

    Economic evaluation of posaconazole vs fluconazole in the prevention of invasive fungal infections in patients with GVHD following haematopoietic SCT by Cámara, R de la, Jarque, I, Sanz, M A, Grau, S, Casado, M A, Sabater, F J, Carreras, E

    Published in Bone marrow transplantation (Basingstoke) (01-05-2010)
    “…Posaconazole has been proven to be as effective as fluconazole in the prevention of invasive fungal infections (IFI) in allogeneic haematopoietic SCT patients…”
    Get full text
    Journal Article
  10. 10

    Cost of allogeneic haematopoietic stem cell transplantation by Duarte, R.F, Patino, B, Munoz, C, Arnan, M, Peralta, T, Clopes, A, Lopez-Belmonte, J.L, de Sevilla, A. Fernandez, Sabater, F.J

    Published in Bone marrow transplantation (Basingstoke) (01-03-2009)
    “…Allogenic haematopoietic stem cell transplantation (alloHSCT) is a well-established treatment for several haematological malignancies. However, little is known…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17